# mesalamine

NDC: 70771-1071
Generic name: mesalamine
Labeler / Manufacturer: Zydus Lifesciences Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, DELAYED RELEASE
Routes: ORAL
Marketing started: 20170619

FDA application: ANDA091640

## Active ingredients

- MESALAMINE: 1.2 g/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70771-1071"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70771-1071
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=29c0dd58-d2cf-40fa-bc32-0eab61937331